Lucy Files with Health Canada To Manufacture Cocaine, Heroin

Forget ketamine and MDMA-based treatments. Psychedelic manufacturing companies are promoting cocaine and heroin use with the ultimate goal of combating fentanyl overdose and drug addiction.

Based in British Columbia Lucy Scientific Discoverya hallucinogen manufacturing company focused primarily on new psychotropic-based drugs, announced today. press release You have submitted an amendment to your current dealer license to Health Canada. The amendment adds cocaine and heroin to the existing list of approved substances the company is allowed to manufacture.

Lucy is already licensed through Health Canada to manufacture several controlled substances, including the psychedelics psilocybin, MDMA, LSD, psilocin, N, N-DMT, mescaline and 2C-B. Adding cocaine and heroin to your portfolio could lead to therapy to combat addiction.

“We are hopeful that Lucy will be able to safely deliver harm reduction programs globally, especially given that fentanyl overdose is the leading cause of death among 18- to 45-year-olds,” said Lucy’s CEO. As one Chris McElvany put it: “It’s time to realize that the failed drug war has done more harm to the global public. Harm reduction programs can help reduce deaths in the long run.” , leading to more treatment options.”

This reflects a sea of ​​change in how controlled substances are being explored for their potential benefits in the medical field. By focusing more on the public health response to the drug crisis, the company is able to offer people who use substances the opportunity to access more harm reduction and treatment options.

Lucy’s Dealer’s license under Part J of the Food and Drug Regulations of the Food and Drugs Act (Canada) was issued by Health Canada’s Agency for Controlled Substances.

This license allows Lucy to develop, market, distribute and manufacture by extracting or synthesizing certain pharmaceutical grade ingredients. The company is also working on active pharmaceutical ingredients (APIs), which are used as raw material precursors in controlled substances.

The company offers raw materials, crude extracts, targeted formulations, single molecule fractions, and white and private label products.

More than ever, there is a need for alternative therapies to control overdose. National Center for Health Statistics at (NCHS) Centers for Disease Control and Prevention Collect data on drug-related deaths commonly associated with fatal overdoses.

106,000+ According to the latest available data, 2021 deaths from drug-related overdoses in the United States. Most are due to prescription opioids and illicit drugs.

Lucy Launches IPO

Lucy began trading on the Nasdaq Capital Market on February 9th. LSDILucy Announces end of IPO As of February 13, total revenue is approximately $7.5 million. After going public in an IPO, Lucy’s management believes the company can make an impact in the field of psychedelic medicine.

Lucy too announced Today McElvany, Lucy Chairman Richard Nanula, and other members of the company’s board and management team will ring the closing bell of the Nasdaq to celebrate the new IPO.

“Today marks a significant milestone for our company, so we are thrilled to celebrate this victory with the NASDAQ’s iconic Bell Ringing Ceremony,” said McElvaney. “We are delighted to celebrate the months of hard work and team effort that led to our successful IPO. , taking the next step in its development is a major achievement.This milestone marks an important step in the company’s growth and expansion plans.We are committed to supporting mental health improvement and treatment. I look forward to the opportunities that lie ahead of us as we continue to work to find sustainable solutions.”

Stay tuned to see where Lucy goes with this latest development.

Disclaimer: High Times is an affiliate of Lucy Scientific Discovery, Inc.